nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CHRM3—ureter—colon cancer	0.0644	0.445	CbGeAlD
Atropine—CHRM3—muscle of abdomen—colon cancer	0.0464	0.32	CbGeAlD
Atropine—CHRM5—epithelium—colon cancer	0.00987	0.0682	CbGeAlD
Atropine—CHRM3—smooth muscle tissue—colon cancer	0.00532	0.0368	CbGeAlD
Atropine—CHRM3—renal system—colon cancer	0.00512	0.0354	CbGeAlD
Atropine—Rash erythematous—Capecitabine—colon cancer	0.00428	0.00501	CcSEcCtD
Atropine—Rash maculo-papular—Fluorouracil—colon cancer	0.00427	0.00499	CcSEcCtD
Atropine—CHRM3—digestive system—colon cancer	0.0042	0.029	CbGeAlD
Atropine—Ageusia—Capecitabine—colon cancer	0.00405	0.00473	CcSEcCtD
Atropine—Petechiae—Capecitabine—colon cancer	0.00399	0.00466	CcSEcCtD
Atropine—Extrasystoles—Capecitabine—colon cancer	0.0039	0.00456	CcSEcCtD
Atropine—CYP1A2—renal system—colon cancer	0.00389	0.0269	CbGeAlD
Atropine—Swelling—Fluorouracil—colon cancer	0.00386	0.00452	CcSEcCtD
Atropine—Disorientation—Fluorouracil—colon cancer	0.00381	0.00445	CcSEcCtD
Atropine—Hyponatraemia—Vincristine—colon cancer	0.00367	0.00429	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.00363	0.00425	CcSEcCtD
Atropine—Ventricular extrasystoles—Capecitabine—colon cancer	0.00363	0.00425	CcSEcCtD
Atropine—Amnesia—Fluorouracil—colon cancer	0.00363	0.00424	CcSEcCtD
Atropine—Hyponatraemia—Irinotecan—colon cancer	0.00357	0.00418	CcSEcCtD
Atropine—Osteoarthritis—Irinotecan—colon cancer	0.00356	0.00416	CcSEcCtD
Atropine—Paralysis—Methotrexate—colon cancer	0.00351	0.00411	CcSEcCtD
Atropine—Lethargy—Fluorouracil—colon cancer	0.00348	0.00407	CcSEcCtD
Atropine—Urinary retention—Vincristine—colon cancer	0.00347	0.00406	CcSEcCtD
Atropine—Cardiac arrest—Vincristine—colon cancer	0.00347	0.00406	CcSEcCtD
Atropine—Dysarthria—Capecitabine—colon cancer	0.00347	0.00405	CcSEcCtD
Atropine—Cyanosis—Methotrexate—colon cancer	0.00345	0.00403	CcSEcCtD
Atropine—Ataxia—Vincristine—colon cancer	0.00343	0.00402	CcSEcCtD
Atropine—Osteoarthritis—Fluorouracil—colon cancer	0.00341	0.00398	CcSEcCtD
Atropine—Dehydration—Vincristine—colon cancer	0.0034	0.00397	CcSEcCtD
Atropine—Cardiac arrest—Irinotecan—colon cancer	0.00338	0.00396	CcSEcCtD
Atropine—Dehydration—Irinotecan—colon cancer	0.00331	0.00387	CcSEcCtD
Atropine—Blood pressure increased—Capecitabine—colon cancer	0.00328	0.00384	CcSEcCtD
Atropine—Stupor—Methotrexate—colon cancer	0.00327	0.00382	CcSEcCtD
Atropine—Injection site reaction—Capecitabine—colon cancer	0.00326	0.00381	CcSEcCtD
Atropine—Irritability—Fluorouracil—colon cancer	0.00325	0.0038	CcSEcCtD
Atropine—Cardiac arrest—Fluorouracil—colon cancer	0.00324	0.00379	CcSEcCtD
Atropine—Hypokalaemia—Irinotecan—colon cancer	0.00324	0.00379	CcSEcCtD
Atropine—Ataxia—Fluorouracil—colon cancer	0.0032	0.00375	CcSEcCtD
Atropine—CYP1A2—digestive system—colon cancer	0.00319	0.022	CbGeAlD
Atropine—Depressed level of consciousness—Capecitabine—colon cancer	0.00317	0.0037	CcSEcCtD
Atropine—Skin exfoliation—Capecitabine—colon cancer	0.00313	0.00366	CcSEcCtD
Atropine—Dry skin—Fluorouracil—colon cancer	0.00312	0.00365	CcSEcCtD
Atropine—Abdominal distension—Irinotecan—colon cancer	0.0031	0.00362	CcSEcCtD
Atropine—Dry eye—Capecitabine—colon cancer	0.00303	0.00354	CcSEcCtD
Atropine—Angina pectoris—Irinotecan—colon cancer	0.003	0.0035	CcSEcCtD
Atropine—Petechiae—Methotrexate—colon cancer	0.00297	0.00347	CcSEcCtD
Atropine—Dysuria—Vincristine—colon cancer	0.00295	0.00345	CcSEcCtD
Atropine—Dysphagia—Fluorouracil—colon cancer	0.00294	0.00344	CcSEcCtD
Atropine—Erectile dysfunction—Vincristine—colon cancer	0.00291	0.0034	CcSEcCtD
Atropine—Angina pectoris—Fluorouracil—colon cancer	0.00287	0.00335	CcSEcCtD
Atropine—Speech disorder—Methotrexate—colon cancer	0.00284	0.00332	CcSEcCtD
Atropine—Depression—Vincristine—colon cancer	0.00281	0.00328	CcSEcCtD
Atropine—Acute coronary syndrome—Vincristine—colon cancer	0.00277	0.00324	CcSEcCtD
Atropine—Myocardial infarction—Vincristine—colon cancer	0.00276	0.00323	CcSEcCtD
Atropine—Acute coronary syndrome—Irinotecan—colon cancer	0.0027	0.00316	CcSEcCtD
Atropine—Swelling—Capecitabine—colon cancer	0.0027	0.00316	CcSEcCtD
Atropine—Sweating—Vincristine—colon cancer	0.0027	0.00316	CcSEcCtD
Atropine—Myocardial infarction—Irinotecan—colon cancer	0.00269	0.00314	CcSEcCtD
Atropine—Eye pain—Capecitabine—colon cancer	0.00264	0.00308	CcSEcCtD
Atropine—Sweating—Irinotecan—colon cancer	0.00263	0.00307	CcSEcCtD
Atropine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00259	0.00303	CcSEcCtD
Atropine—Dysarthria—Methotrexate—colon cancer	0.00258	0.00302	CcSEcCtD
Atropine—Myocardial infarction—Fluorouracil—colon cancer	0.00257	0.00301	CcSEcCtD
Atropine—Conjunctivitis—Fluorouracil—colon cancer	0.00255	0.00298	CcSEcCtD
Atropine—Amnesia—Capecitabine—colon cancer	0.00253	0.00296	CcSEcCtD
Atropine—Hallucination—Vincristine—colon cancer	0.00251	0.00294	CcSEcCtD
Atropine—Atrial fibrillation—Capecitabine—colon cancer	0.00251	0.00294	CcSEcCtD
Atropine—Bradycardia—Irinotecan—colon cancer	0.00251	0.00293	CcSEcCtD
Atropine—Thirst—Capecitabine—colon cancer	0.0025	0.00293	CcSEcCtD
Atropine—Respiratory failure—Methotrexate—colon cancer	0.00249	0.00291	CcSEcCtD
Atropine—Lethargy—Capecitabine—colon cancer	0.00243	0.00284	CcSEcCtD
Atropine—Hyponatraemia—Capecitabine—colon cancer	0.00239	0.0028	CcSEcCtD
Atropine—Osteoarthritis—Capecitabine—colon cancer	0.00238	0.00278	CcSEcCtD
Atropine—CYP1A2—liver—colon cancer	0.00238	0.0164	CbGeAlD
Atropine—Depressed level of consciousness—Methotrexate—colon cancer	0.00236	0.00276	CcSEcCtD
Atropine—Skin exfoliation—Methotrexate—colon cancer	0.00233	0.00273	CcSEcCtD
Atropine—Flushing—Irinotecan—colon cancer	0.00228	0.00267	CcSEcCtD
Atropine—Irritability—Capecitabine—colon cancer	0.00227	0.00266	CcSEcCtD
Atropine—Cardiac arrest—Capecitabine—colon cancer	0.00226	0.00265	CcSEcCtD
Atropine—Urinary retention—Capecitabine—colon cancer	0.00226	0.00265	CcSEcCtD
Atropine—Ataxia—Capecitabine—colon cancer	0.00224	0.00262	CcSEcCtD
Atropine—Coma—Methotrexate—colon cancer	0.00223	0.00261	CcSEcCtD
Atropine—Dehydration—Capecitabine—colon cancer	0.00221	0.00259	CcSEcCtD
Atropine—Mental disorder—Vincristine—colon cancer	0.00221	0.00259	CcSEcCtD
Atropine—Arrhythmia—Irinotecan—colon cancer	0.0022	0.00257	CcSEcCtD
Atropine—Dry skin—Capecitabine—colon cancer	0.00218	0.00255	CcSEcCtD
Atropine—Pulmonary oedema—Methotrexate—colon cancer	0.00217	0.00254	CcSEcCtD
Atropine—Hypokalaemia—Capecitabine—colon cancer	0.00217	0.00253	CcSEcCtD
Atropine—Arrhythmia—Fluorouracil—colon cancer	0.00211	0.00246	CcSEcCtD
Atropine—Abdominal distension—Capecitabine—colon cancer	0.00207	0.00242	CcSEcCtD
Atropine—Dysphagia—Capecitabine—colon cancer	0.00206	0.00241	CcSEcCtD
Atropine—Erythema—Fluorouracil—colon cancer	0.00205	0.0024	CcSEcCtD
Atropine—Agitation—Vincristine—colon cancer	0.00202	0.00236	CcSEcCtD
Atropine—Angina pectoris—Capecitabine—colon cancer	0.002	0.00234	CcSEcCtD
Atropine—Vertigo—Vincristine—colon cancer	0.00198	0.00231	CcSEcCtD
Atropine—Vision blurred—Fluorouracil—colon cancer	0.00193	0.00226	CcSEcCtD
Atropine—Vertigo—Irinotecan—colon cancer	0.00192	0.00225	CcSEcCtD
Atropine—Dysuria—Capecitabine—colon cancer	0.00192	0.00225	CcSEcCtD
Atropine—Syncope—Irinotecan—colon cancer	0.00192	0.00225	CcSEcCtD
Atropine—Convulsion—Vincristine—colon cancer	0.00191	0.00223	CcSEcCtD
Atropine—Loss of consciousness—Irinotecan—colon cancer	0.00188	0.0022	CcSEcCtD
Atropine—Hyperglycaemia—Capecitabine—colon cancer	0.00186	0.00217	CcSEcCtD
Atropine—Depression—Capecitabine—colon cancer	0.00183	0.00214	CcSEcCtD
Atropine—Acute coronary syndrome—Capecitabine—colon cancer	0.00181	0.00211	CcSEcCtD
Atropine—Lethargy—Methotrexate—colon cancer	0.00181	0.00211	CcSEcCtD
Atropine—Myocardial infarction—Capecitabine—colon cancer	0.0018	0.0021	CcSEcCtD
Atropine—Oedema—Vincristine—colon cancer	0.0018	0.0021	CcSEcCtD
Atropine—Anaphylactic shock—Vincristine—colon cancer	0.0018	0.0021	CcSEcCtD
Atropine—Conjunctivitis—Capecitabine—colon cancer	0.00178	0.00209	CcSEcCtD
Atropine—Convulsion—Fluorouracil—colon cancer	0.00178	0.00208	CcSEcCtD
Atropine—Osteoarthritis—Methotrexate—colon cancer	0.00177	0.00207	CcSEcCtD
Atropine—Confusional state—Irinotecan—colon cancer	0.00176	0.00206	CcSEcCtD
Atropine—Oedema—Irinotecan—colon cancer	0.00175	0.00204	CcSEcCtD
Atropine—Anaphylactic shock—Irinotecan—colon cancer	0.00175	0.00204	CcSEcCtD
Atropine—Chest pain—Fluorouracil—colon cancer	0.00175	0.00204	CcSEcCtD
Atropine—Hyperhidrosis—Vincristine—colon cancer	0.00174	0.00203	CcSEcCtD
Atropine—Shock—Irinotecan—colon cancer	0.00172	0.00201	CcSEcCtD
Atropine—Irritability—Methotrexate—colon cancer	0.00169	0.00198	CcSEcCtD
Atropine—Hyperhidrosis—Irinotecan—colon cancer	0.00169	0.00198	CcSEcCtD
Atropine—Confusional state—Fluorouracil—colon cancer	0.00169	0.00197	CcSEcCtD
Atropine—Hypotension—Vincristine—colon cancer	0.00168	0.00196	CcSEcCtD
Atropine—Bradycardia—Capecitabine—colon cancer	0.00168	0.00196	CcSEcCtD
Atropine—Anaphylactic shock—Fluorouracil—colon cancer	0.00167	0.00196	CcSEcCtD
Atropine—Oedema—Fluorouracil—colon cancer	0.00167	0.00196	CcSEcCtD
Atropine—Ataxia—Methotrexate—colon cancer	0.00167	0.00195	CcSEcCtD
Atropine—Tachycardia—Fluorouracil—colon cancer	0.00163	0.00191	CcSEcCtD
Atropine—Hypotension—Irinotecan—colon cancer	0.00163	0.00191	CcSEcCtD
Atropine—Insomnia—Vincristine—colon cancer	0.00162	0.0019	CcSEcCtD
Atropine—Insomnia—Irinotecan—colon cancer	0.00158	0.00185	CcSEcCtD
Atropine—Hypotension—Fluorouracil—colon cancer	0.00156	0.00183	CcSEcCtD
Atropine—Dyspnoea—Irinotecan—colon cancer	0.00156	0.00182	CcSEcCtD
Atropine—Somnolence—Irinotecan—colon cancer	0.00155	0.00182	CcSEcCtD
Atropine—Fatigue—Vincristine—colon cancer	0.00155	0.00181	CcSEcCtD
Atropine—Dyspepsia—Irinotecan—colon cancer	0.00154	0.0018	CcSEcCtD
Atropine—Constipation—Vincristine—colon cancer	0.00154	0.0018	CcSEcCtD
Atropine—Pain—Vincristine—colon cancer	0.00154	0.0018	CcSEcCtD
Atropine—Flushing—Capecitabine—colon cancer	0.00153	0.00179	CcSEcCtD
Atropine—Insomnia—Fluorouracil—colon cancer	0.00151	0.00177	CcSEcCtD
Atropine—Fatigue—Irinotecan—colon cancer	0.00151	0.00176	CcSEcCtD
Atropine—Constipation—Irinotecan—colon cancer	0.0015	0.00175	CcSEcCtD
Atropine—Pain—Irinotecan—colon cancer	0.0015	0.00175	CcSEcCtD
Atropine—Dyspnoea—Fluorouracil—colon cancer	0.00149	0.00175	CcSEcCtD
Atropine—Somnolence—Fluorouracil—colon cancer	0.00149	0.00174	CcSEcCtD
Atropine—Dyspepsia—Fluorouracil—colon cancer	0.00147	0.00172	CcSEcCtD
Atropine—Arrhythmia—Capecitabine—colon cancer	0.00147	0.00172	CcSEcCtD
Atropine—Gastrointestinal pain—Vincristine—colon cancer	0.00147	0.00172	CcSEcCtD
Atropine—Mental disorder—Capecitabine—colon cancer	0.00144	0.00169	CcSEcCtD
Atropine—Feeling abnormal—Irinotecan—colon cancer	0.00144	0.00168	CcSEcCtD
Atropine—Erythema—Capecitabine—colon cancer	0.00143	0.00168	CcSEcCtD
Atropine—Dysuria—Methotrexate—colon cancer	0.00143	0.00167	CcSEcCtD
Atropine—Pain—Fluorouracil—colon cancer	0.00143	0.00167	CcSEcCtD
Atropine—Gastrointestinal pain—Irinotecan—colon cancer	0.00143	0.00167	CcSEcCtD
Atropine—Abdominal pain—Vincristine—colon cancer	0.00142	0.00166	CcSEcCtD
Atropine—Body temperature increased—Vincristine—colon cancer	0.00142	0.00166	CcSEcCtD
Atropine—Erectile dysfunction—Methotrexate—colon cancer	0.00141	0.00165	CcSEcCtD
Atropine—Dysgeusia—Capecitabine—colon cancer	0.0014	0.00164	CcSEcCtD
Atropine—Abdominal pain—Irinotecan—colon cancer	0.00138	0.00162	CcSEcCtD
Atropine—Body temperature increased—Irinotecan—colon cancer	0.00138	0.00162	CcSEcCtD
Atropine—Feeling abnormal—Fluorouracil—colon cancer	0.00138	0.00161	CcSEcCtD
Atropine—Drowsiness—Methotrexate—colon cancer	0.00137	0.0016	CcSEcCtD
Atropine—Depression—Methotrexate—colon cancer	0.00136	0.00159	CcSEcCtD
Atropine—Vision blurred—Capecitabine—colon cancer	0.00135	0.00158	CcSEcCtD
Atropine—Urticaria—Fluorouracil—colon cancer	0.00133	0.00156	CcSEcCtD
Atropine—Conjunctivitis—Methotrexate—colon cancer	0.00133	0.00155	CcSEcCtD
Atropine—Body temperature increased—Fluorouracil—colon cancer	0.00132	0.00155	CcSEcCtD
Atropine—Hypersensitivity—Vincristine—colon cancer	0.00132	0.00155	CcSEcCtD
Atropine—Sweating—Methotrexate—colon cancer	0.00131	0.00153	CcSEcCtD
Atropine—Vertigo—Capecitabine—colon cancer	0.00129	0.00151	CcSEcCtD
Atropine—Hypersensitivity—Irinotecan—colon cancer	0.00129	0.00151	CcSEcCtD
Atropine—Asthenia—Vincristine—colon cancer	0.00129	0.00151	CcSEcCtD
Atropine—Syncope—Capecitabine—colon cancer	0.00129	0.0015	CcSEcCtD
Atropine—Palpitations—Capecitabine—colon cancer	0.00127	0.00148	CcSEcCtD
Atropine—Loss of consciousness—Capecitabine—colon cancer	0.00126	0.00147	CcSEcCtD
Atropine—Asthenia—Irinotecan—colon cancer	0.00125	0.00147	CcSEcCtD
Atropine—Hypersensitivity—Fluorouracil—colon cancer	0.00123	0.00144	CcSEcCtD
Atropine—Diarrhoea—Vincristine—colon cancer	0.00123	0.00144	CcSEcCtD
Atropine—Chest pain—Capecitabine—colon cancer	0.00122	0.00143	CcSEcCtD
Atropine—Anxiety—Capecitabine—colon cancer	0.00122	0.00142	CcSEcCtD
Atropine—Diarrhoea—Irinotecan—colon cancer	0.0012	0.0014	CcSEcCtD
Atropine—Dry mouth—Capecitabine—colon cancer	0.00119	0.0014	CcSEcCtD
Atropine—Dizziness—Vincristine—colon cancer	0.00119	0.00139	CcSEcCtD
Atropine—Pruritus—Fluorouracil—colon cancer	0.00118	0.00139	CcSEcCtD
Atropine—Confusional state—Capecitabine—colon cancer	0.00118	0.00138	CcSEcCtD
Atropine—Oedema—Capecitabine—colon cancer	0.00117	0.00137	CcSEcCtD
Atropine—Dizziness—Irinotecan—colon cancer	0.00116	0.00135	CcSEcCtD
Atropine—Shock—Capecitabine—colon cancer	0.00115	0.00135	CcSEcCtD
Atropine—Diarrhoea—Fluorouracil—colon cancer	0.00115	0.00134	CcSEcCtD
Atropine—Tachycardia—Capecitabine—colon cancer	0.00114	0.00134	CcSEcCtD
Atropine—Vomiting—Vincristine—colon cancer	0.00114	0.00133	CcSEcCtD
Atropine—Rash—Vincristine—colon cancer	0.00113	0.00132	CcSEcCtD
Atropine—Hyperhidrosis—Capecitabine—colon cancer	0.00113	0.00132	CcSEcCtD
Atropine—Dermatitis—Vincristine—colon cancer	0.00113	0.00132	CcSEcCtD
Atropine—Headache—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Atropine—Vomiting—Irinotecan—colon cancer	0.00111	0.0013	CcSEcCtD
Atropine—Dizziness—Fluorouracil—colon cancer	0.00111	0.00129	CcSEcCtD
Atropine—Rash—Irinotecan—colon cancer	0.0011	0.00129	CcSEcCtD
Atropine—Dermatitis—Irinotecan—colon cancer	0.0011	0.00129	CcSEcCtD
Atropine—Headache—Irinotecan—colon cancer	0.0011	0.00128	CcSEcCtD
Atropine—Hypotension—Capecitabine—colon cancer	0.00109	0.00128	CcSEcCtD
Atropine—Mental disorder—Methotrexate—colon cancer	0.00107	0.00126	CcSEcCtD
Atropine—Erythema—Methotrexate—colon cancer	0.00107	0.00125	CcSEcCtD
Atropine—Nausea—Vincristine—colon cancer	0.00107	0.00125	CcSEcCtD
Atropine—Vomiting—Fluorouracil—colon cancer	0.00106	0.00124	CcSEcCtD
Atropine—Insomnia—Capecitabine—colon cancer	0.00106	0.00124	CcSEcCtD
Atropine—Rash—Fluorouracil—colon cancer	0.00106	0.00123	CcSEcCtD
Atropine—Dermatitis—Fluorouracil—colon cancer	0.00105	0.00123	CcSEcCtD
Atropine—Headache—Fluorouracil—colon cancer	0.00105	0.00123	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—colon cancer	0.00105	0.00122	CcSEcCtD
Atropine—Dyspnoea—Capecitabine—colon cancer	0.00104	0.00122	CcSEcCtD
Atropine—Nausea—Irinotecan—colon cancer	0.00104	0.00121	CcSEcCtD
Atropine—Dyspepsia—Capecitabine—colon cancer	0.00103	0.0012	CcSEcCtD
Atropine—Fatigue—Capecitabine—colon cancer	0.00101	0.00118	CcSEcCtD
Atropine—Vision blurred—Methotrexate—colon cancer	0.00101	0.00118	CcSEcCtD
Atropine—Constipation—Capecitabine—colon cancer	0.001	0.00117	CcSEcCtD
Atropine—Pain—Capecitabine—colon cancer	0.001	0.00117	CcSEcCtD
Atropine—Nausea—Fluorouracil—colon cancer	0.000995	0.00116	CcSEcCtD
Atropine—Feeling abnormal—Capecitabine—colon cancer	0.000964	0.00113	CcSEcCtD
Atropine—Vertigo—Methotrexate—colon cancer	0.000959	0.00112	CcSEcCtD
Atropine—Gastrointestinal pain—Capecitabine—colon cancer	0.000957	0.00112	CcSEcCtD
Atropine—Urticaria—Capecitabine—colon cancer	0.00093	0.00109	CcSEcCtD
Atropine—Abdominal pain—Capecitabine—colon cancer	0.000925	0.00108	CcSEcCtD
Atropine—Body temperature increased—Capecitabine—colon cancer	0.000925	0.00108	CcSEcCtD
Atropine—Convulsion—Methotrexate—colon cancer	0.000925	0.00108	CcSEcCtD
Atropine—Chest pain—Methotrexate—colon cancer	0.000909	0.00106	CcSEcCtD
Atropine—Confusional state—Methotrexate—colon cancer	0.000878	0.00103	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—colon cancer	0.000871	0.00102	CcSEcCtD
Atropine—Hypersensitivity—Capecitabine—colon cancer	0.000862	0.00101	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—colon cancer	0.000842	0.000985	CcSEcCtD
Atropine—Asthenia—Capecitabine—colon cancer	0.00084	0.000982	CcSEcCtD
Atropine—Pruritus—Capecitabine—colon cancer	0.000828	0.000968	CcSEcCtD
Atropine—Hypotension—Methotrexate—colon cancer	0.000814	0.000952	CcSEcCtD
Atropine—Diarrhoea—Capecitabine—colon cancer	0.000801	0.000936	CcSEcCtD
Atropine—Insomnia—Methotrexate—colon cancer	0.000788	0.000921	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—colon cancer	0.000777	0.000908	CcSEcCtD
Atropine—Somnolence—Methotrexate—colon cancer	0.000774	0.000906	CcSEcCtD
Atropine—Dizziness—Capecitabine—colon cancer	0.000774	0.000905	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—colon cancer	0.000767	0.000897	CcSEcCtD
Atropine—Fatigue—Methotrexate—colon cancer	0.000751	0.000878	CcSEcCtD
Atropine—Pain—Methotrexate—colon cancer	0.000745	0.000871	CcSEcCtD
Atropine—Vomiting—Capecitabine—colon cancer	0.000744	0.00087	CcSEcCtD
Atropine—Rash—Capecitabine—colon cancer	0.000738	0.000863	CcSEcCtD
Atropine—Dermatitis—Capecitabine—colon cancer	0.000737	0.000862	CcSEcCtD
Atropine—Headache—Capecitabine—colon cancer	0.000733	0.000857	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—colon cancer	0.000718	0.000839	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—colon cancer	0.000712	0.000833	CcSEcCtD
Atropine—Nausea—Capecitabine—colon cancer	0.000695	0.000813	CcSEcCtD
Atropine—Urticaria—Methotrexate—colon cancer	0.000692	0.000809	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—colon cancer	0.000689	0.000805	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—colon cancer	0.000689	0.000805	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—colon cancer	0.000642	0.00075	CcSEcCtD
Atropine—Asthenia—Methotrexate—colon cancer	0.000625	0.000731	CcSEcCtD
Atropine—Pruritus—Methotrexate—colon cancer	0.000616	0.000721	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—colon cancer	0.000596	0.000697	CcSEcCtD
Atropine—Dizziness—Methotrexate—colon cancer	0.000576	0.000674	CcSEcCtD
Atropine—Vomiting—Methotrexate—colon cancer	0.000554	0.000648	CcSEcCtD
Atropine—Rash—Methotrexate—colon cancer	0.000549	0.000642	CcSEcCtD
Atropine—Dermatitis—Methotrexate—colon cancer	0.000549	0.000642	CcSEcCtD
Atropine—Headache—Methotrexate—colon cancer	0.000546	0.000638	CcSEcCtD
Atropine—Nausea—Methotrexate—colon cancer	0.000517	0.000605	CcSEcCtD
